, showing a decrease of Baht 55.30 million or representing 24.14 % decrease since there have been only 5 ongoing projects whereas a subsidiary had 1 additional ongoing project with its contract value of Baht

849.62 Increase(Decrease) (2.39) 65.91 4.62 74.26 142.40 Compared revenue for 6 months (Million Baht) 3 of 8 Operating results classified by business are as follows: Management service business Revenue

Increase (Decrease) % Change Sales income 15,400.82 15,097.66 303.16 2.01% Rental and service income 493.36 480.81 12.55 2.61% Other income 599.77 577.93 21.84 3.78% Total revenues 16,493.95 16,156.40 337.56

necessary items, decrease in spending frequency and low-price favorable from consumer and retailer must also rely on promotion and marketing campaign. (Source : 3Q18 BOT Economic Report/EIC Outlook quarter 4

year, mostly from revenue from UAC which increased Baht 977.69 million, which resulted in the increase in gross profit of Baht 20.62 million and the decrease in gross profit margin for 9-month period of

17.74% 20.03 9.21% 49.42 246.73% Jul – Sep 63 Jul – Sep 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2

and its subsidiary for the third quarter ended September 30, 2019 which the details are as follows: Unit: million Baht For 3-month period (July-Sep) 2019 2018 Change % Increase (Decrease) Revenue from

in Q1-2023. Total operating expenses in Q2-2023 have changed in the same direction and at a similar rate with the increase and decrease in revenue when compared to Q1- 2023 and Q2- 2022. However, the

2018 as follow: DuPont Analysis 2017 2018 2019 Return on Equity or ROE 15 (%) 14.55 8.37 9.08 Operating Profit Margin 12 (%) 12.12 8.29 9.13 Total Assets Turnover 18 (times) 1.03 0.96 0.93 Equity

.) as follow: no Item Book Value as of 30 Sep 2017 (THB Million) Fair Value (Nov 2017) (THB Million) 1 Land (2 plots with title deeds no. 2182 and 3802 having total area of 23 rai, 32 Sq.wah.) and